Showing all 4 results
Esomeprazole & Levosulpiride Capsules
FreeEsomeprazole and Levosulpiride capsules are a combination medication primarily used for gastroesophageal reflux disease (GERD) and peptic ulcers in patients who do not respond to a proton pump inhibitor (PPI) alone.
Levosulpiride Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Rapid-Burst Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the benzamide derivative.
Active Ingredient Strength Primary Clinical Function Levosulpiride USP/Ph.Eur. 25 mg Global Gastroenterology Standard: Base therapeutic unit taken prior to meals for the rapid relief of functional dyspepsia, bloating, and mild gastroparesis. Levosulpiride USP/Ph.Eur. 50 mg / 75 mg Psychiatric & Severe Dysmotility Standard: High-efficacy adult therapy used for severe, treatment-resistant diabetic gastroparesis or utilized by psychiatrists for somatoform disorders and mild depression. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Crospovidone / Colloidal Silicon Dioxide / Magnesium Stearate Diluent / Superdisintegrant / Binder / Glidant (Engineered specifically without heavy polymeric retardants to guarantee immediate, complete gastric dissolution within 10 to 15 minutes of ingestion, preparing the stomach for the incoming meal) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict, meal-dependent acute and chronic dispensing regimens).
Pantoprazole And Levosulpiride Capsules
FreePantoprazole and levosulpiride capsules are a combination therapy used for gastrointestinal conditions where excess acid is accompanied by motility issues. They are most commonly available in a fixed-dose strength of 40 mg (enteric-coated) and 75 mg (sustained-release).Rabeprazole & Levosulpiride Capsules
FreeRabeprazole and levosulpiride capsules are a common combination used to treat gastrointestinal disorders where acid reflux is accompanied by bloating or delayed stomach emptying. They are most frequently available in a fixed-dose strength of 20 mg (enteric-coated) and 75 mg (sustained-release).
